Enjoy complimentary customisation on priority with our Enterprise License!
The external urine management products market size is estimated to grow at a CAGR of 6.11% between 2022 and 2027. The market size is forecasted to increase by USD 5,465.63 million. The growth of the market depends on several factors, including the adoption of external urine management products in hospitals, the expanding healthcare industry, and immense growth opportunities in emerging countries.
This external urine management products market report extensively covers market segmentation by end-user (hospitals, diagnostic laboratories and clinics, and homecare settings), product (male external catheters, female external catheters, and urine collection accessories), and geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
To learn more about this report, View Report Sample
The adoption of external urine management products in hospitals is notably driving the market growth, although factors such as increasing cases of urinary infections may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The adoption of external urine management products in hospitals is notably driving the market growth. The prevalence of urinary incontinence is increasing across the world, which is boosting the growth of the market. External urine management products, such as catheters and external urine collection devices, are used to manage urinary incontinence, urinary retention, and other urinary-related issues. The adoption of these products depends on several factors, such as hospital policies and protocols, the availability of trained staff, and the preferences of individual healthcare providers and patients.
The development of advanced urinary incontinence devices and the increasing prevalence of urological issues are expected to have a positive impact on market growth. Urological issues are more common in the geriatric population. In addition, the increasing number of bladder cancer patients is anticipated to have a major impact on market growth. The use of external urine management products has grown owing to the need for long-term UI management alternatives, which, in turn, will fuel the growth of the market during the forecast period.
The rising prevalence of chronic conditions is a key trend influencing the market. Chronic conditions such as diabetes, multiple sclerosis, spinal cord injuries, and prostate cancer can result in urinary incontinence. This can increase the need for external urine management products such as catheters, condom catheters, and urine bags. The number of individuals with chronic conditions and urinary incontinence is increasing, which is fueling the demand for external urine management products. This is expected to boost sales during the forecast period.
According to the World Health Organization (WHO), chronic diseases were responsible for more than 70% of all deaths worldwide in 2022, and this figure is expected to increase during the forecast period. Moreover, the rise in the aging population is contributing to the prevalence of urinary incontinence. Thus, the demand for external urine management products is increasing. The likelihood of developing urinary incontinence is high among the geriatric population, which, in turn, drives the demand for these products. These factors will support the growth of the global external urine management products market during the forecast period.
The increasing number of cases of urinary infections may impede the market growth. External urine management products can increase the chances of infection as well as other complications, including skin irritation and bladder spasms. This can be a major concern for individuals who need to use these products in the long term. Urinary tract infection (UTI) is one of the most common complications. It occurs when bacteria enter the urinary tract through the catheter.
Other complications of external urine management products include blockage or obstruction of the catheter, which can cause urine to reach back into the bladder and lead to bladder or kidney damage and leakage around the catheter. This can also cause skin irritation and infection. Thus, infections and complications associated with the use of external urine management products will negatively impact the growth of the market during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global External Urine Management Products Market Customer Landscape
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
B. Braun Melsungen AG - The company offers external urine management products such as Actreen intermittent catheters.
The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
The market share growth by the hospitals segment will be significant during the forecast period. Hospitals need external urine management products for patients with specific medical conditions, such as urinary incontinence, urinary retention, or bladder dysfunction. Patients who undergo surgery, such as pelvic surgery or prostate surgery, may require temporary external urine management products to drain urine from their bladder.
Get a glance at the market contribution of various segments View the PDF Sample
The hospitals segment was valued at USD 6,247.41 million in 2017 and continued to grow until 2021. External urine management products can help reduce the risk of urinary tract infections and other complications associated with urinary catheterization, which may increase the demand for these products in hospitals. Thus, the increasing use of urine management products in hospitals will drive the growth of the hospitals segment during the forecast period.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 39% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The growth of the external urine management products market in North America can be attributed to factors such as the rising geriatric population, the increasing prevalence of prostate and bladder cancer, and the presence of established vendors. The geriatric population in North America is rising. The US is the major revenue contributor to the market in the region.
This report forecasts the contribution of all the segments to the growth of the market. In addition, we have included the COVID-19 impact and the recovery strategies for each segment. In 2020, due to the COVID-19 pandemic, the number of patients requiring external urine management products increased. However, the pandemic led to disruptions in the global supply chain, which negatively impacted the availability of external urine management products. In 2021, large-scale vaccination across the region led to the removal of lockdown restrictions, which resulted in the reopening of manufacturing units. During the forecast period, the increasing number of chronic disease cases will boost the demand for external urine management products in North America.
The external urine management products market report forecasts market growth by revenue at global, regional, & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
Technavio categorizes the external urine management products market as a part of the global life science tools and services market. The parent market, the global life science tools and services market, covers products and companies engaged in research and development (R&D) of a variety of product categories, including capital equipment, instruments, accessories, and consumables that are used for R&D on pharmaceuticals and biotechnology products and laboratory diagnosis of various diseases. It also covers life sciences-related services, including contract research, contract manufacturing, and contract sales. Our market research report has extensively covered external factors influencing the parent market growth during the forecast period.
External Urine Management Products Market Scope |
|
Report Coverage |
Details |
Page number |
153 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.11% |
Market growth 2023-2027 |
USD 5,465.63 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
5.55 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 39% |
Key countries |
US, China, Japan, Germany, and France |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
B. Braun Melsungen AG, Becton Dickinson and Co., BioDerm Inc., Boehringer Laboratories LLC, Cardinal Health Inc., Coloplast AS, Consure Medical, ConvaTec Group Plc, GPC Medical Ltd., GWS Surgicals LLP, Hollister Inc., Manish Medi Innovation, Medevis Rubplast India Pvt. Ltd., Medline Industries LP, Spectrum Plastics Group, Sterimed Medical Devices Pvt. Ltd., Stryker Corp., Teleflex Inc., Tilla Care Ltd., and Hospital Equipment Manufacturing Co. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.